← Retour 🔗 Vue partagée — Acme Corporation · Lecture seule

Expression of interest: Precision prevention: biological mechanisms of response variation

Medical Research Council (MRC) · UKRI Funding Opportunity · GB
2.0
Score global

Résumé

This Medical Research Council (MRC) funding call invites applications to study biological mechanisms underlying differential human responses to biomedical prevention interventions, with the goal of advancing precision prevention through better targeting of interventions. Applicants must be based at a UK research organisation eligible for MRC funding and must generate mechanistic evidence in humans. The application deadline is 17 September 2026.

Analyse d'adéquation

This call focuses on biomedical prevention interventions and human mechanistic research in a medical/health context, which is tangential at best to Acme Corporation's core domains of semiconductors and AI. The call explicitly requires applicants to be based at UK research organisations eligible for MRC funding, making a for-profit semiconductor company ineligible. There is no meaningful overlap with the client's strategic priorities.

Scores détaillés

Pertinence 2.0/10
Urgence 6.0/10
Adéquation stratégique 1.0/10

Brief exécutif

Low

Pas d'analyse approfondie — ce score ≤ 6,0 n'a pas déclenché l'analyse détaillée. Voir l'analyse d'adéquation ci-dessus.

Description

Apply for funding to study why people respond differently to biomedical prevention interventions. Projects must generate mechanistic evidence in humans to provide insight into precision prevention through better targeting. You must be based at a UK research organisation eligible for MRC funding.

Source officielle
Voir l'appel ↗